Photonic frontiers in melasma: Navigating layers, risks, and the future of light-based therapeutics

IPL

IPL generates a non-coherent broadband (500–1200 nm) and has many applications, with the largest utilization being epidermal and mixed melasma. Clinical trials have shown the potential of IPL to reduce the melasma area and severity index (MASI) by 50% or more with the use of topical agents, typically hydroquinone or triple-combination nonhydroquinone creams.^[9] In another study, a 40% decrease in melanin index was observed with the combination of IPL and hydroquinone compared with only a 12% decrease. Yet, 24–33% recurrence has been reported in 6 months, most commonly in Fitzpatrick skin type IV–V patients. The risks are post-inflammatory hyperpigmentation (PIH), especially when high fluences are used without photoprotection.^[10]

QSND lasers

QSND lasers (1064 nm) are directed at dermal melanin with the aid of selective photothermolysis. Low-fluence QSND (the “laser toning” technique) is particularly effective in epidermal type. Wattanakrai et al.^[11] reported that the diminution of the MASI scores reached an improvement of 50–60% after a series of ten sessions. Nevertheless, recurrences are frequent (up to 64%), and a second treatment can aggravate mottled healthy skin.^[11]

NAFL

The NAFL devices (e.g., 1550 nm erbium-glass) produce tiny areas of thermal heating, which trigger the dermal remodeling effect with very little dermal disruption. In the study conducted by Cho et al., better results were shown in moderate degrees of improvement and lengthier remission in comparison to QSND and with fewer side effects.^[12]

AFL

AFL de-pigment by shearing columns of epidermal and dermal tissue, making it easier to clear the pigment and increase drug penetration. Although they can provide such improvement, PIH improvement occurs faster on lighter skin, and recurrence is frequent unless it is treated concomitantly by maintenance therapy.^[13]

Picosecond lasers

Lasers that we use in the picosecond domain provide ultrashort pulses, breaking up pigment with minimal thermal damage. Their safety profile is improved in Asian skin than in QSND, but the efficacy could be a little inferior.^[14] Table 2 describes the different light-based treatment options in melasma, such as IPL, Q-switched lasers, fractional lasers, and low-fluence laser toning, and their mechanisms, indications, and clinical results.

The layers-light interaction matrix

Conventional categorization of melasma treatment tends to distinguish between epidermal and dermal treatments. Nonetheless, an integrative strategy may be structured as a Schema of Layers-Light interaction associating certain wavelengths with histological targets and differentiating between therapeutic and aggravating effects.^[15] As a case in point, low-fluence QSND (1064 nm) can penetrate the dermis and selectively refract the dermal melanin, whereas HEVL (400–450 nm) exacerbates pigmentation by forming free radicals and exerting oxidative stress processes. Using such a bidirectional model, clinicians can now visualize light as a treatment as well as a risk depending on wavelength, fluence, and patient phototype.^[16]

PBM and adjunctive light approaches

PBM or low-level light therapy (LLLT) is low-intensity red or near-infrared light, with pericellular doses, to moderate cells. Limited study data indicate that PBM could decrease melanogenesis, inflammation, and vascularity of the dermis in melasma.^[17] In a small study monitoring the use of 940 nm PBM after microdermabrasion, pigment improvement was noted to be significant with few side effects.^[18] Future randomized trials should be larger in size.

High-energy visible light (HEVL)

The binding of opsin-3 causes the formation of oxidative stress and melanin in the melanocytes exposed to HEVL, 400–450 nm (blue violet) light.^[19] Its symptoms are more evident in darker phototypes, causing long-term hyperpigmentation.

UVA-1

Long-wave UVA-1 (340–400 nm) reaches the dermis layer, where it stimulates melanocytes and dermis changes by triggering photoaging that can be a continuing perpetuating factor in melasma.^[20]

LED masks and consumer devices

Recent professional opinions warn against the uncontrolled application of red and blue LED mask devices in place of melasma-prone individuals, as the stimulation of melanocytes with a subsequent increase of heat is possible.^[21] The most significant environmental risk factors of melasma, including chronic sun exposure, heat, pollution, and UV radiation, are mentioned in Table 3, with a particular focus on their capability to cause and worsen hyperpigmentation.

Device-based therapies in melasma

Inadequacy of conventional melasma treatments, such as topical depigmenting agents and chemical peels in treating melanin, has led to the investigation into device-based treatment modalities that may have better-targeted depth of action and also respond to changes in the underlying dermis.^[22] It has given way to what can now be called the layers and light paradigm of treatment, a treatment philosophy based on the simultaneous realization that it is critically important to correctly infer the histological depth of pigmentation and that device parameters, at least wavelength and pulse parameters, need to be matched to that depth to most effectively and safely work.^[23]

Histological classification has been the mainstay of personalized selection of devices. Epidermal melasma, when the pigment is located in the basal and suprabasal keratinocyte, is more sensitive to shorter waves and low penetration (e.g., 532 nm potassium titanyl phoshate (KTP) lasers or even specific IPL filters).^[24] Conversely, dermal melasma, where melanophages are located in the mid and superficial dermis, will need longer wavelengths, i.e., 1064 nm Nd:YAG, that penetrate deeper without causing significant damage. A staged or combination therapy process, where the shallow and the deep penetrating devices are used sequentially, is often required with mixed-type melasma to treat pigment at both superficial and deeper levels.^[25]

IPL, QSND lasers, NAFL, AFL, picosecond lasers, and LLLT are all popular modes of devices.^[26] These skin technologies both break up the size of melanin granules as well as stimulate neocollagenesis, dermal matrix integrity, and reverse photoaging alterations that predispose to melasma.^[27] Specifically, fractional photothermolysis has become a flexible alternative due to its ability to apply energy in microthermal zones, which facilitates faster recovery and reduces the risk of PIH in dark skin types.^[28]

Device parameters should meet the need for a balance between pigment-targeting efficiency and treatment-induced inflammation, which is paradoxically capable of inducing melanogenesis. Reducing the pulse duration is often preferred to hit pigment without much thermal diffusion and reducing cumulative trauma by use of lower fluences in repeat applications. To complement effects, topical agents including antioxidants, retinoids, or tranexamic acid, known to inhibit melanocyte activity and enhance skin barrier function, may be applied in combination.^[29]

The major points of risk prevention include recognizing that a higher Fitzpatrick skin type (IV, V, VI) since a risk factor of PIH, rebound melasma, hypopigmentation, and texture change are more significant.^[30] To achieve the best result, rigorous pre-procedure priming is required with topical depigmenting agents, energy titration should be done with care, and photoprotection should be carried out after the procedure. Moreover, exposure to the environment-light, not only UV radiation but also visible light present in sunlight, and in the indoor environment, represents a continuing risk to the treatment longevity. As such, visible-light-blocking agents in broad-spectrum sunscreens (e.g., iron oxide) are useful in long-term management.^[31]

Risk factors and complications

The safety concerns related to adverse pigmentary changes versus the efficacy of device-based therapies for melasma, particularly light and laser-based therapies, are a delicate matter that needs close attention and consideration.^[32] Although these interventions are very effective in creating desirable pigment clearance, the wrong device type employed, suboptimal staring parameters, and poor patient preparations can exacerbate pigmentation and undermine success. Risk evaluation is a crucial component of the layers and light approach, guiding both therapeutic decision-making and patient counseling.^[33] Figure 1 below shows the treatment selection flowchart of melasma, which gives a step-by-step procedure on how to select proper therapies depending on the severity of the disease, the type of skin, and the reaction of the patient.

Close

Figure 1:

Treatment selection flowchart.

Export to PPT

Proposed photonic risk index (PRI)

PRI is a proposed quantitative instrument that will be used to stratify patients based on their risk of adverse photonic effects and recurrence when receiving laser or light-based treatment. The PRI takes into consideration a number of parameters (patient-specific factors), lesion-specific factors, and treatment-specific factors to produce a composite risk score. This helps in the planning of treatments individually; the delivery of energy is maximized and safer.^[34]

Example calculation

Consider a patient with the following profile:

• Fitzpatrick skin type IV → Score = 1

• Dermal pigmented lesion → Score = 2

• Wavelength slightly suboptimal → Score = 2

• Moderate fluence → Score = 1

• One prior recurrence → Score = 1

Calculation:

PRI = (1×0.25) + (2×0.20) + (2×0.15) + (1×0.20) + (1×0.20) = 0.25 + 0.40 + 0.30 + 0.20 + 0.20 = 1.35 → Moderate Risk

This patient would be managed with conservative fluence escalation, potentially more test spots, and follow-up scheduled within 2–4 weeks post-treatment.

Clinical utility

Treatment planning: PRI can help clinicians choose the wavelength, fluence, pulse length, and cooling regimens to reduce side effects like PIH or scarring.^[35]

Patient counseling: It enables the communication of individualized risk, which enhances informed consent and the compliance of the patient.

Follow-up strategy: With increased PRI scores, more conservative intervals of observation and treatment are recommended, minimizing recurrence and adverse events.

Research and audit: A standardized framework can be used to document outcomes and later compare results across groups of patients.

PIH

The most prevalent and serious complication is PIH. It occurs most commonly in individuals with darker Fitzpatrick (IV-VI) skin types, as these are associated with an overall rise in the sensitization of pigment-producing melanocytes to inflammation. In the presence of AFL (2125%) and a QSND laser (2335%), the occurrence of PIH was maximal with AFLs and QSNs.^[36] Such statistics justify the reason behind using conservative energy fluences, sufficient cooling, and preparation of the priming with an off-coloring agent.

Recurrence

Chronic, relapsing melasma often leads to the reappearance of pigment despite repeated device treatments. Recurrence within 1 year without maintenance therapy is estimated to occur in 50–70% of cases. Unprotected UV and visible light doses, hormonal factors, and subclinical inflammation following a procedure are frequently predisposing causes of rebound pigmentation.^[37] The long-term success depends on the continued follow-up therapy, which is a combination of wide-spectrum photoprotection, topical tyrosinase inhibitors, and low-energy touch-ups every now and then.

Mottled hypopigmentation

Repeated QSND laser toning, especially with cumulative high-energy doses, can induce mottled hypopigmentation due to melanocyte destruction and uneven pigment regrowth. This risk is aggravated in cases where treatment is administered too swiftly since the epidermis is denied an adequate place. This must be reduced by ensuring that protocols minimize session-to-session usage and with invasive pigment checks at the earliest onset of changes.^[38]

Thermal triggers

Heat, whether produced by laser or light treatment or even environmental sun exposure, can worsen melasma by promoting the formation of new dermal blood vessels and the up-regulation of vascular endothelial cells. Such vascular alterations may result in continuous inflammation and melanogenesis. To prevent unnecessary thermal loading, it is recommended to avoid treatments in hot climates without allowing adequate recovery periods and to use sub-purpuric settings with sufficient skin cooling.^[39]

Suboptimal photoprotection

Even the best laser or light therapy may be defeated by a lack of proper pre- and post-treatment photoprotection. Regular sunscreens fail to provide adequate coverage for HEVL and UVA-1, which are the two factors that contribute to their persistence and recurrence. Iron oxide mineral sunscreens have the advantage of being particularly helpful in the prevention of HEVL and must be included in a daily routine practice.^[40]

Combination therapies and future directions

Combination regimens (i.e., IPL or NAFL with topical depigmenting agents or oral tranexamic acid, respectively) have shown greater efficacy with lower recurrence rates in comparison to monotherapy.^[41] These synergetic strategies not only aim at short-cutting several pathogenic pathways but also reduce the intensity of each single treatment to attain reduced risk exposure to PIH and other pigmentary disorders.

Maintenance therapy is not optional but essential to the device-based management of melasma, as its relapse rates are high. The mainstay of a long-term treatment regime, when it comes to the timely use of sunscreens, includes wide-range sunscreens that also contain iron oxide, daily topical pigment suppressors, and infrequent low-intensity device sessions. Patient education regarding heat avoidance, the concept of strict photoprotection, and the following of the appointment plans is also important in keeping people longer in the therapeutic effect.^[42]

Precision light-based therapy: The choice of the device is based on melasma type (epidermal vs. dermal), vascular constituent, and phototype.

• Laser-assisted drug delivery: With the help of fractional lasers, penetration of agents like tranexamic acid or hydroquinone is assisted, which has the potential to increase efficacy, and side effects are minimized^[43]

• Lowered PBM protocols: Set-ups that entail low energy and short re-treatment intervals that avoid heat damage, though they also address the melanocytes process by adjusting the fluence, wavelength, and re-treatment interval^[44]

• Smart photoprotection: Textiles and sunscreens that contain HEVL-blocking textiles and a real-time light sensor.^[45]

Smart Photoprotection 2.0: Advances in Photoprotection: Next-generation approaches include wearable light sensors that alert patients to harmful sun exposure, iron oxide– embedded textiles, and adaptive SPF software. Wearable light sensors that warn a patient when the sun is dangerous, iron oxide-laden textiles, and adaptive SPF software through a smartphone are the next generation of melasma protection. With close digital monitoring and enhanced ingredients, Smart Photoprotection 2.0 provides immediate protection and reduces the recurrence of the issue.^[46]

Non-invasive imaging biomarkers: Hyperspectral imaging and reflectance confocal microscopy to identify depths of pigmentation and vascularity to make modifications to treatment.

Engineering Solutions: Engineering to reduce heat-minimizing devices: Heat is minimized by rational engineering of systems to produce cooling of light to reduce heat-mediated melanogenesis.^[47]